MPP’s written submission to the 154th session of the Executive Board of the WHO (document EB152/12) 

Statement delivered under:  

Pillar 2: One billion more people better protected from health emergencies. 

Speaker: Tiwadayo Braimoh

Medicines Patent Pool (MPP) notes paragraphs 6 and 7 of the report on health emergency prevention, preparedness, and response (EB154/5).  

While transitioning the management of the COVID-19 pandemic to a more sustainable approach, it is important to ensure that equitable access to countermeasures remains in focus, not just for COVID-19 but also future pandemics. MPP would like to highlight the need to build on and strengthen mechanisms such as licensing and technology transfer through which several affordable versions of COVID-19 treatments are now available to low- and middle-income countries. It is also important to sustain the capacities being built through the mRNA Vaccine Technology Transfer programme.  

MPP continues to be available to work with the WHO and partners to build on lessons learnt during the COVID-19 pandemic for equitable access to innovative health technologies in the future.   

Thank you!